retatrutide weight loss clinical trials results Results: 24% in 48 Weeks Retatrutide approval: FDA status, clinical

These suggest a possible kidney infection (pyelonephritis), which requires prompt treatment with antibiotics

Snen krevnho tlaku: U pacient uvajcch Retatrutid dolo ke snen systolickho a diastolickho tlaku, co vedlo k zastaven nebo snen uvn antihypertenziv

That's what Phase 3 trials are designed to assess

However, there is still no definite explanation as to why it happens

Contact your doctor immediately if you experience: Severe or persistent headaches Blurred vision or confusion Dizziness or fainting Nausea and vomiting that prevent hydration Signs of an allergic reaction (rash, swelling, or difficulty breathing) These could indicate more serious side effects of semaglutide or other potential complications requiring professional medical advice

Daniel Rosen, a NYC-based surgeon and weight-loss doctor, has taken to TikTok to share the unusual complication he has observed in patients using GLP-1 drugs